Welcome and Greeting from The Medical Director, Dr. Jeffrey Karr
Clinic Contact Phone Number:
The Osteomyelitis Center of Central Florida focuses on the treatment and preservation of bone infections only of the lower leg, ankle, and foot. This center is a private clinic founder by myself. Initially consultation will be in my private clinic. Please contact the office at 863-646-5960 for an appointment and forward your clinical information to firstname.lastname@example.org or by mail prior to your first visit after reviewing the " Patients - In Preparation Of Your Office Visit/Consultation" tab to the left. Sending your the requested outlined information to prior to your visit is very important. Not doing so may delay your treatment. Please understand we are not a referral service. If you have a bone infection other than your lower leg, ankle, or foot you willed to contact a different physician.
Typically, after the initial clinic evaluation you will be scheduled for surgery quickly to address your bone infection. I can not stress enough that to provide you a smooth evaluation and transition to possible resolution it is extremely important to review and follow the instructions at the left tab entitled " Patients - In Preparation Of Your Office Visit/Consultation".
You will be also evaluated for other factors that negatively impact healing and will provide the support needed during the healing process to allow the patient to heal and return to family, hobbies, and work. This includes but is not limited to lower extremity peripheral arterial disease, tobacco use, diabetes, or compliance.
WHATS GOING ON
October 13, 2014 Mulheim, Germany
Dr. Karr will be attending an osteomyelitis cadaver meeting attended by surgeons from Germany, Italy, Spain, Denmark, UK, Switzerland, Austria, Netherlands and Poland.
September is PAD Awareness Month
June 26, 2014 at 6 pm Dinner on DFU's and growth factors hosted by The Osteomyelitis Center. please rsvp and attend at 1-813-732-2607
January 17, 2014
Advances in the Treatment of Osteomyelitis - SAM 2014 symposium in Orlando, FL. www.fpma.com
9-20-13 Just published by Dr. Karr and Dr. Pham:
Online Exclusive: A Case Presentation: The Successful Management of Complicated Wounds in the Presence of an Infected Knee Prosthesis With Silver Antimicrobial Negative Pressure Dressing and a Negative Pressure Wound Therapy Device. www.woundresearch.com.
The History of the Center, Research, and Outcomes - What It Means to you.
The following is summery of the work done for the Percutaneous Antibiotic Delivery Technique (PAD-T). This minimally invasive (percutaneous) single stage technique was invented and pioneered by myself in 2009 for treating osteomyelitis. I am in my third decade of treating osteomyelitis and that experience will allow me to provide the highest level of care for your lower extremity bone infection. I am here to help you.The Percutaneous Antibiotic Delivery Technique (PAD-T) is the first such percutaneous delivery technique for treating osteomyelitis not only within the United States but globally.
The PAD-T was invented, developed, and successfully used long term by myself in 2009 as a means to deliver antibiotics percutaneously with a flowable bone void filler carrier into an area of bone infection allowing complete bone penetration and contact with the adherent bone surface bacteria/biofilm obtaining significant drug elusion and drug levels in the area of bone infection. This technique avoids a more invasive, multiple bone surgeries such as placing and removing non-absorbable antibiotic beads. The PAD-T minimizes time away from work, does not require external fixation, and generally requires no change in weight bearing status.
Historical PAD-T Information
First bone void filler for osteomyelitis white paper - Karr, JC. Management of a Diabetic Patient Presenting with Forefoot Osteomyelitis Utilizing Cerament™|Bone Void Filler Impregnated with Vancomycin– Off Label Use. White paper. Bone Support. June 2009.
First bone void filler for osteomyelitis publication - Karr, JC. Management of a Diabetic Patient Presenting with Forefoot Osteomyelitis: The use of Cerament™ |Bone Void Filler Impregnated with Vancomycin – An off Label Use. The Journal of Diabetic Foot Complications: 2009, 1 (4), No. 3. pp. 94-100.
Symposium presentation - Biocompatible, Injectable Ceramic Antibiotic Impregnated Bone Substitute (Cerament) Minimal Inhibitory Concentration Against Methacillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. APMA Nation meeting. Toronto, Canada. July 2009.
Product development for Bone Support using Cerament bone void filler as a flowable carrie vehicle with antibiotics to treat osteomyelitis 2009 - 2011.
Bacterial in vitro publication - Karr, JC, Keriazes G, Lautetta J. In Vitro Antimicrobial Activity of Calcium Sulfate and Hydroxyapatite (Cerament™| Bone Void Filler) Discs Utilizing Heat Sensitive and Heat Non-Sensitive Antibiotics against Methicillin Resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Journal of American Podiatric Medical Association Journal. Vol 101, No. 2, March/April 2011.
Symposium presentation - IN VITRO ANTIMICROBIAL ACTIVITY OF CALCIUM SULFATE AND HYDROXYAPATITE DISC OF HEAT SENSITIVE AND HEAT NON-SENSITIVE ANTIBIOTICS AGAINST METHICILLIN RESISTANT STAPHLOCOCCUS AUREUS (MRSA) AND PSEUDOMONAS AERUGINOSA. European Bone and Joint Infectious Disease Society. September 14-17, 2011 Copenhagen, Denmark.
Numerous white papers for Bone Support - #1 Fibular Osteomyelitis Following Ankle Surgery, Management with Flowable Percutaneous Calcium Sulfate and Hydroxyapitite (Cerament Bone Void Filler) and Vancomyacin, #2 Calcaneal Osteomyelitis Following Elective Foot Surgery and Management with Flowable Percutaneous Calcium Sulfate and Hydroxyapitite (Cerament Bone Void Filler) with Tobramycin and Vancomyacin. #3 The Management of Infected Ankle Arthrodesis with Removal of Internal Fixation and Intra-osseous Delivery of Calcium Sulfate and Hydroxyapitite (Cerament Bone Void Filler) with Vancomyacin #4 Mid-foot Charcot deformity with Osteomyelitis and Diabetic Foot Ulcers: Management with Flowable Percutaneous Calcium Sulfate and Hydroxyapitite (Cerament Bone Void Filler) with Vancomyacin 2011.
Physician education - BGU Krankenhaus Hospital Duisberg, Germany September 13, 2011.
Cerament – Clinical Results in Osteomyelitis
Physician education - University Hospital Mainz, Germany September 14, 2011. Bone Void Filler Cerament for Restorative Trauma and Osteomyelitis
Symposium presentation - European Bone and Joint Infectious Disease Society. September 14-17, 2011 Copenhagen,Denmark. PATIENT CASE SERIES OF INTRAOSSEOUS OSTEOMYEILTIS TRETAEMENT WITH CALCIUM SULFATE AND HYDROXYAPITITE BONE VOID FILLER IMPREGNATED WITH EITHER ANTIBIOTIC OR ANTIFUNGAL MEDICATION. 2011.
The Osteomyelitis Center of Central Florida Clinic and website launched 2012.
USA Patent (US 20120129761 A1) May 24, 2012. Preparation of bone cement compositions
Symposium presentation - European Bone and Joint Infectious Disease Society. Percutaneous antibiotic delivery techinique for osteomyelitis. September 20-22, 2012 Montreux, Switzerland
Symposium presentation - TM’s 1st World Virology and Microbiology Online conference. Session 8: Anti-Infection Treatments 14:30 PM – 16:00 PM Session Chair: Dr. David H. Van Thiel. Presentation Title: In vitro anti-bacterial and anti-fungal properties and human osteomyelitis management outcomes with calcium sulfate and hydroxyapatite (cerement) bone void filler impregnated with either antibiotic or antifungal medication. 2012.
Symposium presentation - TM’s 2nd World Virology and Microbiology Online conference. Session 8: Anti-Infection Treatments 14:30 PM – 16:00 PM Session Chair: Dr. David H. Van Thiel. Presentation Title: Treatment of Osteomyelitis with a percutaneous approach. 2013.
Physician teaching - Cadaver workshop for osteomyelitis. Dusseldorf, Germany. Bone Support.
Physical education - Advances in the Treatment of Osteomyelitis - SAM 2014 symposium in Orlando, FL. www.fpma.com
Fungal in vitro publication - Karr, JC, Lautetta J. In Vitro Anti-fungal Disc Activity of Calcium Sulfate and Hydroxyapatite (Cerament™| Bone Void Filler) Loaded with Amphotericin B or Voriconazole for Consideration in Adjunctive Osteomyelitis Management. JAPMA Feb 105(2) 2015
Point-Counterpoint: Is Surgical Treatment The Best Option For Forefoot Osteomyelitis? Podiatry Today
July 3, 2016.
Physician education - February 2nd 2016, Online discussion about osteomyelitis treatment at Podiatricsuccess.com. This is an open forum where you can participate and ask questions.
Technique/procedure publication - An Overview of the Percutaneous Antibiotic Delivery Technique for Osteomyelitis Treatment and aCase Study of Calcaneal Osteomyelitis. Journal of the American Podiatric Medical Association,Vol. 107, No. 6, November 2017: 511-515.
Pending for publication May/June 2018 - Karr, JC. Lower Extremity Osteomyelitis Treatment Utilizing Calcium Sulfate/Hydroxyapatite Bone Void Filler With Antibiotics: Seven-Year Retrospective Study.
- Contact Information and location
- A message from Dr. Karr and some general information
- Patients - In preparation of your on line questions
- Patients - In preparation of your first office visit
- Percutaneous Antibiotic Delivery Technique (PAD-T) Video
- How and Why The PAD-T Works
- Patient outcomes
- Osteomyelitis treatment options
- Conference Lectures
- International Conference Presentations
- Emerging New Techniques
- Patient Testimonials
- Frequently asked questions
- Lakeland Vascular Institute
- Community Outreach
- Case presentations
- Anti-Discrimination Notice – Section 1557 15 Top Florida Foreign Languages